Webinar Series
The 5 Molecular Profiles of MammaPrint + BluePrint in ER+/HER2- Early Breast Cancer

Join us for this webinar series as Dr. William Audeh reviews each of the five MammaPrint + BluePrint genomic profile classifications and the unique answers each provides for treatment considerations in ER+/HER2- early-stage breast cancer.
Presented by:
William Audeh, MD, MS
Chief Medical Officer
Agendia

- MP High 2 – Basal BluePrint – 30 mins: Wednesday May 14th
- During this webinar series, Dr. William Audeh will review each of the five molecular profiles identified in ER+/HER2- patients with MammaPrint and BluePrint 150-gene assay platform. In this 30 minute webinar, Dr. Audeh will review the data and clinical utility with a MammaPrint High 2 + BluePrint Basal result.
- 5:30PM CEST:
- 5:30PM EST:
- 5:30PM PST:
- MP High 2 – Luminal B BluePrint – 30 mins: Wednesday May 21st
- During this webinar series, Dr. William Audeh will review each of the five molecular profiles identified in ER+/HER2- patients with MammaPrint and BluePrint 150-gene assay platform. In this 30 minute webinar, Dr. Audeh will review the data and clinical utility with a MammaPrint High 2 + BluePrint Luminal B result.
- 5:30PM CEST:
- 5:30PM EST:
- 5:30PM PST:
- MP High 1 – Luminal B BluePrint – 30 mins: Wednesday June 11th
- During this webinar series, Dr. William Audeh will review each of the five molecular profiles identified in ER+/HER2- patients with MammaPrint and BluePrint 150-gene assay platform. In this 30 minute webinar, Dr. Audeh will review the data and clinical utility with a MammaPrint High 1 + BluePrint Luminal B result.
- 5:30PM CEST:
- 5:30PM EST:
- 5:30PM PST:
- MP Low – Luminal A BluePrint – 30 mins: Wednesday June 18th
- During this webinar series, Dr. William Audeh will review each of the five molecular profiles identified in ER+/HER2- patients with MammaPrint and BluePrint 150-gene assay platform. In this 30 minute webinar, Dr. Audeh will review the data and clinical utility with a MammaPrint Low + BluePrint Luminal A result.
- 5:30PM CEST:
- 5:30PM EST:
- 5:30PM PST:
- MP UltraLow – Luminal A BluePrint – 30 mins: Wednesday June 25th
- During this webinar series, Dr. William Audeh will review each of the five molecular profiles identified in ER+/HER2- patients with MammaPrint and BluePrint 150-gene assay platform. In this 30 minute webinar, Dr. Audeh will review the data and clinical utility with a MammaPrint UltraLow + BluePrint Luminal A result.
- 5:30PM CEST:
- 5:30PM EST:
- 5:30PM PST: